Welcome to LookChem.com Sign In|Join Free
  • or
1-(3-BROMOPROPOXY)-3-NITROBENZENE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

31191-43-2

Post Buying Request

31191-43-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31191-43-2 Usage

Chemical structure

1-(3-bromopropoxy)-3-nitrobenzene is an organic compound with a benzene ring, a nitro group (NO2), a bromine atom, and a propoxy group (C3H7O) attached to it.

Appearance

It is a colorless to pale yellow liquid.

Solubility

Insoluble in water, but soluble in organic solvents.

Molecular weight

Approximately 276.09 g/mol

Functional groups

Nitro group (NO2), bromine atom, and propoxy group (C3H7O)

Position of functional groups

Nitro group is at the 3rd position, bromine atom is at the 1st position, and propoxy group is at the para position (1,3-disubstituted benzene).

Applications

Primarily used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, dyes, and pigments.

Hazards

Toxicity and potential hazards to human health and the environment.

Safety precautions

Handle with caution, use appropriate personal protective equipment (PPE), and follow safety guidelines to minimize exposure and environmental impact.

Check Digit Verification of cas no

The CAS Registry Mumber 31191-43-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,1,9 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 31191-43:
(7*3)+(6*1)+(5*1)+(4*9)+(3*1)+(2*4)+(1*3)=82
82 % 10 = 2
So 31191-43-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10BrNO3/c10-5-2-6-14-9-4-1-3-8(7-9)11(12)13/h1,3-4,7H,2,5-6H2

31191-43-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3-bromopropoxy)-3-nitrobenzene

1.2 Other means of identification

Product number -
Other names 3-Bromopropyl 3-nitrophenyl ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31191-43-2 SDS

31191-43-2Relevant academic research and scientific papers

Non-destructive erasable molecular switches and memory using light-driven twisting motions

Kawamoto, Masuki,Shiga, Natsuki,Takaishi, Kazuto,Yamashita, Takashi

, p. 8344 - 8346 (2010)

Novel types of chiroptical switches and memory with non-destructive readout that are entirely optically controlled for molecular devices in solution and neat films.

Identification of a novel click-derived 1,2,3-triazole as selective Hg2+ ion detector: computational and experimental investigations

Ujan, Rabail,Arshad, Nasima,Perveen, Fouzia,Channar, Pervaiz Ali,Lal, Bhajan,Hussain, Mumtaz,Hussain, Zahid,Saeed, Aamer,Shehzadi, Syeda Aaliya

, p. 6377 - 6388 (2021)

A new triazole-substituted compound (7), namely {5-((2-methyl-4-(3-methyl-4-(prop-2-ynyloxy) benzyl) phenoxy) methyl)-1-(3-(nitrophenoxy) propyl)-1h-1, 2, 3-triazole}, was synthesized through the coupling of azido and propargylated precursors via click ap

Light-driven reversible handedness inversion in self-organized helical superstructures

Mathews, Manoj,Zola, Rafael S.,Hurley, Shawn,Yang, Deng-Ke,White, Timothy J.,Bunning, Timothy J.,Li, Quan

, p. 18361 - 18366 (2010)

We report here a fast-photon-mode reversible handedness inversion of a self-organized helical superstructure (i.e., a cholesteric liquid crystal phase) using photoisomerizable chiral cyclic dopants. The two light-driven cyclic azobenzenophanes with axial

Piperazine substituted 1, 3 - di-substituted urea compound and piperazine substituted amide compounds and a method for its preparation and use

-

Paragraph 0155-0157, (2017/04/22)

The present invention relates to a class of piperazine substituted 1,3-disubstitued urea compounds and piperazine substituted amide compounds, or pharmaceutically acceptable salts of the piperazine substituted 1,3-disubstitued urea compounds and the piper

Optically active compound and its use

-

Paragraph 0047-0048, (2016/12/22)

PROBLEM TO BE SOLVED: To provide a new compound which varies optical rotation by irradiation with light. SOLUTION: The optically active compound is represented by formula (1) (wherein X is each independently -NH2, -N(CH3)2, -H, -F, -I, -Br, -Cl, -COOH or the like; and a and b are integers in the range of 1-6). COPYRIGHT: (C)2011,JPOandINPIT

Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties

Huang, Shao-Xu,Li, Hui-Yuan,Liu, Jun-Yan,Morisseau, Christophe,Hammock, Bruce D.,Long, Ya-Qiu

supporting information; experimental part, p. 8376 - 8386 (2011/02/21)

The inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of hypertension, inflammation, and other disorders. However, the problems of limited water solubility, high melting point, and low metabolic stabil

Improved model of lanosterol 14α-demethylase by ligand-supported homology modeling: Validation by virtual screening and azole optimization

Sheng, Chunquan,Wang, Wenya,Che, Xiaoying,Dong, Guoqiang,Wang, Shengzheng,Ji, Haitao,Miao, Zhenyuan,Yao, Jianzhong,Zhang, Wannian

experimental part, p. 390 - 397 (2010/11/18)

Lanosterol 14α-demethylase (CYP51) is an important target for antifungal drugs. An improved three-dimensional model of CYP51 from Candida albicans (CACYP51) was constructed by ligand-supported homology modeling and molecular dynamics simulations. The accuracy of the constructed model was evaluated by its performance in a small-scale virtual screen. The results show that known CYP51 inhibitors were efficiently discriminated by the model, and it performed better than our previous CACYP51 model. The active site of CACYP51 was characterized by multiple copy simultaneous search (MCSS) calculations. On the basis of the MCSS results, a series of novel azoles were designed and synthesized, and they showed good in vitro antifungal activity with a broad spectrum. The MIC80 value of four of these compounds against C. albicans is 0.001 μgmL-1, indicating that they are promising leads for the discovery of novel antifungal agents.

New azoles with potent antifungal activity: Design, synthesis and molecular docking

Che, Xiaoying,Sheng, Chunquan,Wang, Wenya,Cao, Yongbing,Xu, Yulan,Ji, Haitao,Dong, Guoqiang,Miao, Zhenyuan,Yao, Jianzhong,Zhang, Wannian

scheme or table, p. 4218 - 4226 (2009/12/09)

In response to the urgent need for novel antifungal agents with improved activity and broader spectrum, computer modeling was used to rational design novel antifungal azoles. On the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51), a series of new azoles with substituted-phenoxypropyl piperazine side chains were rational designed and synthesized. In vitro antifungal activity assay indicates that the new azoles show good activity against most of the tested pathogenic fungi. Interestingly, the designed compounds are also active against an azole-resistant clinical strain. Compared to fluconazole and itraconazole, several compounds (such as 12i, 12j and 12n) show higher antifungal activity and broader spectrum, which are promising leads for the development of novel antifungal agents.

IMIDAZO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS

-

Page/Page column 131, (2009/07/03)

Compounds of formula I that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula I and therapeutically acceptable salts, prodrugs and salts of prodrugs thereof, wherein X is CH or N; A1 is R1, OR1. NHR1, N(R1)2, NHC(O)R1, NHC(O)NHR1, NHC(O)N(R1)2, NHC(O)OR1, C(O)NHR1, C(O)N(R1)2, C=NOR1, or C(NH2)NOC(O)R1;

Muscarinic acetylcholine receptor antagonists

-

Page/Page column 17, (2008/06/13)

Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 31191-43-2